您的位置: 首页 > 农业专利 > 详情页

NOVEL ANTI-IGF-IR ANTIBODIES AND THEIR APPLICATIONS
专利权人:
PIERRE FABRE MEDICAMENT
发明人:
LILIANE GOETSCH,NATHALIE CORVAIA
申请号:
FR0507829
公开号:
FR2888850B1
申请日:
2005.07.22
申请国别(地区):
FR
年份:
2013
代理人:
摘要:
Isolated antibody (Ab) and its functional fragments, able to bind to the human receptor for insulin-like growth factor I (IGF-1R) and/or to inhibit specifically the tyrosine kinase activity of IGF-IR are new. Ab inhibits natural binding of the ligand (IGF1) to IGF-1R with IC50 less than 0.3, preferably 0.03, nM and also inhibits binding of IGF2 to the same receptor with IC50 less than 0.1, preferably 0.1, nM. Independent claims are also included for the following: (1) murine hybridoma that secretes Ab; (2) antibodies, and their fragments, produced by the hybridomas of (1); (3) isolated nucleic acid (NA) that is (a) DNA or RNA encoding Ab or its functional fragments; (b) complements of (a); (c) fragments of at least 18 nucleotides (nt) that hybridize under highly stringent conditions to any of Seq. (9)-(14) (reproduced) or with sequences having at least 80% identify after optimal alignment; or (d) fragments of at least 18 nt that hybridize under highly stringent conditions to light/heavy chain encoding sequences (Seq. (15) and (16)) or with sequences having at least 80% identity; (4) vector that contains NA; (5) host cell that contains the vector of (4); (6) non-human transgenic animal containing a cell transformed by the vector of (4); (7) method for producing Ab or its functional fragments; (8) in vitro diagnosis of diseases caused by under- or over-expression of IGF-1R by treating a test sample with optionally labeled Ab; (9) kit for method (8); (10) in vitro method for identifying a modulator of IGF-1R; (11) method for detecting a binding partner of Ab; and (12) method for purifying IGF-1R. ACTIVITY : Cytostatic; Antipsoriatic; Antiarteriosclerotic. Antibodies from hybridoma I-3499 were tested against the androgen-dependent prostate cancer DU145, injected subcutaneously into athymic, nude, female mice. The antibody was given in 0.2 mg doses 24 hours after cell implantation, then twice weekly. Tumor volumes were 60 and 130 mm 3>; after 12 and 20 days, in untreat
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充